THE WOODLANDS, Texas (AP) — THE WOODLANDS, Texas (AP) — Lexicon Pharmaceuticals Inc. (LXRX) on Thursday reported a loss of $53.4 million in its second quarter.
On a per-share basis, the The Woodlands, Texas-based company said it had a loss of 17 cents.
The results beat Wall Street expectations. The average estimate of four analysts surveyed by Zacks Investment Research was for a loss of 18 cents per share.
The drugmaker posted revenue of $1.6 million in the period, which missed Street forecasts. Three analysts surveyed by Zacks expected $2.7 million.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on LXRX at https://www.zacks.com/ap/LXRX